User profiles for Giorgio Guzzetta

Giorgio Guzzetta

Researcher, Fondazione Bruno Kessler
Verified email at fbk.eu
Cited by 3565

Evaluation of waning of SARS-CoV-2 vaccine–induced immunity: a systematic review and meta-analysis

F Menegale, M Manica, A Zardini, G Guzzetta… - JAMA network …, 2023 - jamanetwork.com
Importance Estimates of the rate of waning of vaccine effectiveness (VE) against COVID-19
are key to assess population levels of protection and future needs for booster doses to face …

[HTML][HTML] Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020

…, A Siddu, O Punzo, F Trentini, G Guzzetta… - …, 2020 - eurosurveillance.org
Background On 20 February 2020, a locally acquired coronavirus disease (COVID-19) case
was detected in Lombardy, Italy. This was the first signal of ongoing transmission of severe …

The early phase of the COVID-19 outbreak in Lombardy, Italy

…, M Ajelli, P Poletti, F Trentini, G Guzzetta… - arXiv preprint arXiv …, 2020 - arxiv.org
In the night of February 20, 2020, the first case of novel coronavirus disease (COVID-19) was
confirmed in the Lombardy Region, Italy. In the week that followed, Lombardy experienced …

[HTML][HTML] Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from …

…, BF De Blasio, SJ De Vlas, G Guzzetta… - The Lancet Public …, 2016 - thelancet.com
Background Modelling studies have been widely used to inform human papillomavirus (HPV)
vaccination policy decisions; however, many models exist and it is not known whether they …

Association of age with likelihood of developing symptoms and critical disease among close contacts exposed to patients with confirmed SARS-CoV-2 infection in Italy

…, M Tirani, D Cereda, F Trentini, G Guzzetta… - JAMA network …, 2021 - jamanetwork.com
Importance Solid estimates of the risk of developing symptoms and of progressing to critical
disease in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-…

[HTML][HTML] Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021

J Yang, V Marziano, X Deng, G Guzzetta… - Nature human …, 2021 - nature.com
COVID-19 vaccination is being conducted in over 200 countries and regions to control
SARS-CoV-2 transmission and return to a pre-pandemic lifestyle. However, understanding when …

Probability of symptoms and critical disease after SARS-CoV-2 infection

…, M Tirani, D Cereda, F Trentini, G Guzzetta… - arXiv preprint arXiv …, 2020 - arxiv.org
We quantified the probability of developing symptoms (respiratory or fever \geq 37.5 {\deg}C)
and critical disease (requiring intensive care or resulting in death) of SARS-CoV-2 positive …

[HTML][HTML] Early estimates of monkeypox incubation period, generation time, and reproduction number, Italy, May–June 2022

G Guzzetta, A Mammone, F Ferraro… - Emerging infectious …, 2022 - ncbi.nlm.nih.gov
We analyzed the first 255 PCR-confirmed cases of monkeypox in Italy in 2022. Preliminary
estimates indicate mean incubation period of 9.1 (95% CI 6.5–10.9) days, mean generation …

Retrospective analysis of the Italian exit strategy from COVID-19 lockdown

V Marziano, G Guzzetta… - Proceedings of the …, 2021 - National Acad Sciences
After the national lockdown imposed on March 11, 2020, the Italian government has gradually
resumed the suspended economic and social activities since May 4, while maintaining the …

[HTML][HTML] The early phase of the COVID-19 epidemic in Lombardy, Italy

…, V Demicheli, M Ajelli, P Poletti, F Trentini, G Guzzetta… - Epidemics, 2021 - Elsevier
Background In the night of February 20, 2020, the first epidemic of the novel coronavirus
disease (COVID-19) outside Asia was uncovered by the identification of its first patient in …